The Cancer Cash Cow
Cancerâa word that strikes fear into the hearts of manyâis not just a disease; it's a multi-billion-dollar industry. In 2023, global spending on cancer medicines reached
$223 billion, marking a $25 billion increase from 2022. This expenditure is projected to grow significantly, potentially reaching $409 billion by 2028.
Letâs talk about cancer treatments. You know, the ones that cost hundreds of thousands of dollars, make you vomit your guts out, lose your hair, and leave you so weak you can barely function.
Chemotherapy and radiation are the gold standard, right? Well, what if we told you there are cheap, widely available, and far less toxic drugs that have shown remarkable promise in treating cancerâdrugs like
ivermectin and
fenbendazole? But wait, you wonât hear about these from your oncologist. Why? Because Big Pharma canât make billions off drugs that cost pennies, and Big Pharma owns medical education in the USA! Thatâs why!
Letâs dive into the science and the scandal of why these treatments are being ignored while the âcancer industrial complexâ keeps pushing its toxic, profit-driven agenda.
|
| |
Ivermectin: Not Just for Horses and Parasites
Ivermectin, the drug that became a household name during the COVID-19 pandemic (and was promptly demonized by the media, has been quietly making waves in cancer research. According to a study published in
Frontiers in Pharmacology, ivermectin exhibits
anti-cancer properties by targeting multiple pathways involved in tumor growth and survival. It inhibits the Wnt/β-catenin pathway, which is crucial for cancer cell proliferation, and induces apoptosis (programmed cell death) in cancer cells while sparing healthy ones.
A 2021 study in
Anticancer Research found that ivermectin significantly reduced the viability of breast cancer cells and enhanced the efficacy of conventional chemotherapy drugs. Another study in
The Moss Report highlighted its ability to disrupt cancer cell metabolism and inhibit angiogenesis (the formation of new blood vessels that feed tumors).
But hey, why use a cheap, well-tolerated drug when you can pump patients full of expensive, toxic chemo cocktails?
|
| |
Fenbendazole and Mebendazole: Dewormers That Deworm Cancer
Fenbendazole and mebendazole are anti-parasitic drugs commonly used to treat worms in animals and humans. But guess what? They also have potent anti-cancer properties.
A groundbreaking study published in PMC (PubMed Central) demonstrated that fenbendazole disrupts cancer cell metabolism by inhibiting glucose uptake and microtubule formation, effectively starving cancer cells to death.
The same study showed that fenbendazole, when combined with vitamin E and a high-fat diet, significantly reduced tumor growth in mice. Similarly,
mebendazole has been shown to inhibit glioblastoma (brain cancer) by targeting cancer stem cells and disrupting their ability to proliferate.
But wait, thereâs more! A
2023 article in Natural News highlighted the
synergistic pairing of ivermectin and fenbendazole, which together create a powerful anti-cancer protocol. This combination has been shown to enhance apoptosis, inhibit tumor growth, and even prevent metastasis.
Yet, despite this mounting evidence, these drugs remain on the sidelines, relegated to the realm of âalternativeâ treatments. Why? Because theyâre cheap, unpatentable, and donât require a team of specialists to administer.
Must-Watch Video: Avoid Mouthwash (Use this Nobel Prize Breakthrough Instead).
Why pain lingers long after an injury or diagnosis
This is about getting your life backâon your terms.
9 key medicinal herbs
